Your Gateway to the US Pharma Market
GPP Team
Rob Camerer
CEO
BS Chemistry
BS Chemical Engineering
MBA International Studies
36 years experience in the Specialty Pharma, Rare Diseases Pharma, Complex Injectables, Biologicals, Peptides and Small Molecules Industries
Joseph Corsetti
President
MBA, JD, CPA
Executive Management
Business Development and Portfolio Management. Commercial Development, Marketing
Jonathan Camerer
Executive Vice President
BS Marketing
Bachelors in Marketing
Business Development
Accounting
Event Coordination
Corporate Communications
Josh Camerer
BD Manager
BS Administrative Management
Portfolio Analysis
Pipeline Development
Accounting
Promotional Materials
Graphic Design
Vince Mancinelli
Chief Operating Officer
Bachelors in Biology
Grad studies in Pharmaceutical Sciences
Vince is Chief Operating Officer for GPP. He brings over 37 years of leadership experience in the pharmaceutical industry marked by success in growing start-up businesses and creating value for growth specialty brand and generic companies. His career began at Mylan where he steadily advanced in leadership roles including subsidiary head of UDL Laboratories and Mylan’s Head of North American Operations. Other prior C-level leadership roles include President of Rhodes Pharmaceuticals. He is a strategic adviser / consultant for pharmaceutical companies assisting with product portfolios, business development, product licensing and acquisitions, enterprise innovation, integration, and complex market and commercialization strategies.
Kuntal Chatterjee
Global President of BD
MSc - Microbiology
MBA -Pharmaceutical Mgmt
Kuntal has around 22 plus years of experience in RA, Quality, Portfolio, and BD topics.
He has worked in various senior leadership roles at Dr. Reddys, Sandoz, Woerwag, Apotex, Aurobindo, and Berlin Chemie.
​
Currently, from Nov 2020. Kuntal is a freelancer BD Consultant for GPP, assisting companies globally with their portfolio and BD strategy to grow their global business and helping them with market access, Licensing needs, Business growth, and M&A activities. He is also assisting senior and board-level introductions with Pharma bosses globally
